Latest Taxation News

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Careteq Limited signals progress on its 1-System platform integration with a planned Q3 FY26 restart, while Embedded Health Solutions expands aged care contracts and the company navigates a significant ATO R&D tax objection.

Wrkr Ltd has reported a strong start to FY26 with its third consecutive quarter of positive operating cash flow and a successful $15 million capital raise, positioning the fintech for accelerated growth ahead of major client launches.

Pivotal Metals Limited has announced a C$2.6 million flow-through share offer targeting Canadian investors, aimed at funding critical minerals exploration in Quebec. The offer complements a concurrent institutional placement, underscoring the company’s aggressive growth strategy amid significant operational risks.

Southern Palladium Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to $30,000 at $1.10 per share, aiming to raise $1 million to advance its Bengwenyama mine project in South Africa.

Acumentis Group Limited reported a robust FY25 with a 35% jump in operating profit, driven by strategic diversification and operational efficiency. The company is optimistic about FY26, anticipating economic improvements and new growth avenues.

Air New Zealand has revised its first half 2026 financial outlook to a pre-tax loss between NZD 30 million and 55 million, citing weaker revenue growth and rising costs. The airline is pushing cost-saving measures while highlighting uncertainties ahead.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

Ryder Capital Limited has announced a 20% increase in its annual dividend, moving to quarterly payments starting January 2026, enhancing income certainty for shareholders.

333D Ltd reports a fifth consecutive quarter of revenue growth, secures $1 million in fresh capital, and expands its blockchain healthcare initiatives while building a strategic Bitcoin treasury.